E
NBSE

Ergoteles’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Ergoteles’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,895
Closed -$7.21K – 1890
2022
Q4 		$7.21K Buy
+1,895
New +$7.21K ﹤0.01% 1378
2021
Q4 		– Sell
-3,728
Closed -$269K – 1672
2021
Q3 		$269K Sell
3,728
-105
-3% -$7.58K 0.01% 853
2021
Q2 		$367K Buy
+3,833
New +$367K 0.01% 964